Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Allergy and Asthma Reports
Erschienen in: Current Allergy and Asthma Reports 7/2022

01.04.2022 | Allergic Skin Diseases (L Fonacier, Section Editor)

Aeroallergens in Atopic Dermatitis and Chronic Urticaria

verfasst von: Albert C. Chong, Won Jong Chwa, Peck Y. Ong

Erschienen in: Current Allergy and Asthma Reports | Ausgabe 7/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

While aeroallergens are a well-established trigger of asthma and allergic rhinitis, their role in allergic skin diseases such as atopic dermatitis and chronic urticaria remains controversial. This paper reviews the pathophysiology and clinical evidence for aeroallergens in these allergic skin diseases and summarizes current strategies for evaluation and management.

Recent Findings

Current evidence implicates aeroallergens as triggers of cutaneous reactions in atopic dermatitis. Direct skin contact is the likely route of trigger. Aeroallergens may also trigger chronic urticaria, though mechanistic studies are limited. These allergens may cross the skin barrier and directly trigger neurons to release substance P, resulting in mast cell degranulation and dumping of histamine and prostaglandin D2. Many studies link aeroallergen sensitization to chronic urticaria, and case reports suggest the utility of avoidance strategies.

Summary

The role of aeroallergens as a trigger is clear in atopic dermatitis and becoming emergent in chronic urticaria. Skin prick testing or serum-specific immunoglobulin E testing may be used to determine sensitivities. Management at this time centers on avoidance, and further studies are necessary to evaluate the efficacy of aeroallergen immunotherapy for both conditions.
Literatur
1.
Martorano L, Erwin EA. Aeroallergen Exposure and Spread in the Modern Era. J Allergy Clin Immunol Pract. 2018;6:1835–42.PubMedCrossRef
2.
3.
Farrokhi S, Gheybi MK, Movahed A, et al. Common aeroallergens in patients with asthma and allergic rhinitis living in southwestern part of Iran: based on skin prick test reactivity. Iran J Allergy Asthma Immunol. 2015;14:133–8.PubMed
4.
Craig TJ. Aeroallergen sensitization in asthma: prevalence and correlation with severity. Allergy Asthma Proc. 2010;31:96–102.PubMedCrossRef
5.
Eiringhaus K, Renz H, Matricardi P, et al. Component-Resolved Diagnosis in Allergic Rhinitis and Asthma. J Appl Lab Med. 2019;3:883–98.PubMedCrossRef
6.
7.
Tamagawa-Mineoka R, Katoh N. Atopic Dermatitis: Identification and Management of Complicating Factors. Int J Mol Sci. 2020;21:E2671.PubMedCrossRef
8.
Odhiambo JA, Williams HC, Clayton TO, et al. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol. 2009;124:1251-1258.e23.PubMedCrossRef
9.
Silverberg JI, Hanifin JM. Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study. J Allergy Clin Immunol. 2013;132:1132–8.PubMedCrossRef
10.
Sandhu JK, Wu KK, Bui T-L, et al. Association Between Atopic Dermatitis and Suicidality: A Systematic Review and Meta-analysis. JAMA Dermatol. 2019;155:178–87.PubMedCrossRef
11.
David Boothe W, Tarbox JA, Tarbox MB. Atopic Dermatitis: Pathophysiology. Adv Exp Med Biol. 2017;1027:21–37.PubMedCrossRef
12.
Silverberg JI, Hanifin J, Simpson EL. Climatic factors are associated with childhood eczema prevalence in US. J Invest Dermatol. 2013;133:1752–9.PubMedPubMedCentralCrossRef
13.
•• Werfel T, Heratizadeh A, Niebuhr M, et al. Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber. J Allergy Clin Immunol 2015; 136:96–103.e9. The first double-blind placebo-controlled study which confirmed aeroallergens as a direct trigger in atopic dermatitis.
14.
Badorrek P, Dick M, Emmert L, et al. Pollen starch granules in bronchial inflammation. Ann Allergy Asthma Immunol. 2012;109:208-14.
15.
van der Heijden FL, Joost van Neerven RJ, van Katwijk M, et al. Serum-IgE-facilitated allergen presentation in atopic disease. J Immunol. 1993;150:3643–3650.
16.
Maurer D, Ebner C, Reininger B, et al. The high affinity IgE receptor (Fc epsilon RI) mediates IgE-dependent allergen presentation. J Immunol. 1995;154:6285–90.PubMed
17.
Sharquie IK, Al-Ghouleh A, Fitton P, et al. An investigation into IgE-facilitated allergen recognition and presentation by human dendritic cells. BMC Immunol. 2013;14:54.PubMedPubMedCentralCrossRef
18.
Novak N, Bieber T, Kraft S. Immunoglobulin E-bearing antigen-presenting cells in atopic dermatitis. Curr Allergy Asthma Rep. 2004;4:263–9.PubMedCrossRef
19.
Cooper D, Hales J, Camp R. IgE-Dependent Activation of T cells by Allergen in Atopic Dermatitis: Pathophysiologic Relevance. J Investig Dermatol. 2004;123:1086–91.PubMedCrossRef
20.
21.
22.
Oetjen LK, Mack MR, Feng J, et al. Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch. Cell. 2017;171:217-228.e13.PubMedPubMedCentralCrossRef
23.
Gandhi NA, Bennett BL, Graham NMH, et al. Targeting key proximal drivers of type 2 inflammation in disease. Nat Rev Drug Discov. 2016;15:35–50.PubMedCrossRef
24.
Werfel T, Breuer K, Ruéff F, et al. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy. 2006;61:202–5.PubMedCrossRef
25.
26.
Trautmann A, Akdis M, Kleemann D, et al. T cell–mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest. 2000;106:25–35.PubMedPubMedCentralCrossRef
27.
De Benedetto A, Rafaels NM, McGirt LY, et al. Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol. 2011;127(773–786):e1-7.
28.
Yoshida K, Kubo A, Fujita H, et al. Distinct behavior of human Langerhans cells and inflammatory dendritic epidermal cells at tight junctions in patients with atopic dermatitis. J Allergy Clin Immunol. 2014;134:856–64.PubMedCrossRef
29.
Brandner JM, Zorn-Kruppa M, Yoshida T, et al. Epidermal tight junctions in health and disease. Tissue Barriers. 2015;3: e974451.
30.
Lee CH, Chuang HY, Hong CH, et al. Lifetime exposure to cigarette smoking and the development of adult-onset atopic dermatitis. Br J Dermatol. 2011;164:483–9.PubMedPubMedCentral
31.
Endo K, Hizawa T, Fukuzumi T, et al. [Keeping dogs indoor aggravates infantile atopic dermatitis]. Arerugi. 1999;48: 1309–1315.
32.
Jaworek AK, Szafraniec K, Jaworek M, et al. Cat Allergy as a Source Intensification of Atopic Dermatitis in Adult Patients. Adv Exp Med Biol. 2020;1251:39–47.PubMedCrossRef
33.
Pónyai G, Hidvégi B, Németh I, et al. Contact and aeroallergens in adulthood atopic dermatitis. J Eur Acad Dermatol Venereol. 2008;22:1346–55.PubMedCrossRef
34.
Kutlu A, Karabacak E, Aydin E, et al. Relationship between skin prick and atopic patch test reactivity to aeroallergens and disease severity in children with atopic dermatitis. Allergol Immunopathol. 2013;41:369–73.CrossRef
35.
Tan BB, Weald D, Strickland I, et al. Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis. Lancet. 1996;347:15–8.PubMedCrossRef
36.
Oosting A-J, de Bruin-Weller MS, Terreehorst I, et al. Effect of mattress encasings on atopic dermatitis outcome measures in a double-blind, placebo-controlled study: the Dutch mite avoidance study. J Allergy Clin Immunol. 2002;110:500–6.PubMedCrossRef
37.
Kim J, Lee S, Woo S, et al. The Indoor Level of House Dust Mite Allergen Is Associated with Severity of Atopic Dermatitis in Children. J Korean Med Sci. 2013;28:74–9.PubMedPubMedCentralCrossRef
38.
Sanda T, Yasue T, Oohashi M, et al. Effectiveness of house dust-mite allergen avoidance through clean room therapy in patients with atopic dermatitis. J Allergy Clin Immunol. 1992;89:653–7.PubMedCrossRef
39.
Colloff MJ, Lever RS, McSharry C. A controlled trial of house dust mite eradication using natamycin in homes of patients with atopic dermatitis: effect on clinical status and mite populations. Br J Dermatol. 1989;121:199–208.PubMedCrossRef
40.
Holm L, Bengtsson A, van Hage-Hamsten M, et al. Effectiveness of occlusive bedding in the treatment of atopic dermatitis–a placebo-controlled trial of 12 months’ duration. Allergy. 2001;56:152–8.PubMedCrossRef
41.
Katoh N, Hirano S, Suehiro M, et al. Soluble CD30 is more relevant to disease activity of atopic dermatitis than soluble CD26. Clin Exp Immunol. 2000;121:187–92.PubMedPubMedCentralCrossRef
42.
Novak N, Bieber T, Hoffmann M, et al. Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis. J Allergy Clin Immunol. 2012;130:925-931.e4.PubMedCrossRef
43.
Pajno GB, Caminiti L, Vita D, et al. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol. 2007;120:164–70.PubMedCrossRef
44.
•• Langer SS, Cardili RN, Melo JML, et al. Efficacy of House Dust Mite Sublingual Immunotherapy in Patients with Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial. The Journal of Allergy and Clinical Immunology: In Practice. Epub ahead of print 10 November 2021. https://​doi.​org/​10.​1016/​j.​jaip.​2021.​10.​060. A double-blind placebo-controlled trial showing the efficacy of house dust mite sublingual immunotherapy in atopic dermatitis.
45.
Patella V, Florio G, Palmieri M, et al. Atopic dermatitis severity during exposure to air pollutants and weather changes with an Artificial Neural Network (ANN) analysis. Pediatr Allergy Immunol. 2020;31:938–45.PubMedCrossRef
46.
•• Wassmann-Otto A, Heratizadeh A, Wichmann K, et al. Birch pollen-related foods can cause late eczematous reactions in patients with atopic dermatitis. Allergy 2018; 73: 2046–2054. Interesting study showing the trigger of atopic dermatitis by pollen-related foods.
47.
Reekers R, Busche M, Wittmann M, et al. Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens. J Allergy Clin Immunol. 1999;104:466–72.PubMedCrossRef
48.
Heratizadeh A, Wichmann K, Werfel T. Food allergy and atopic dermatitis: how are they connected? Curr Allergy Asthma Rep. 2011;11:284–91.PubMedCrossRef
49.
Anderson LB, Dreyfuss EM, Logan J, et al. Melon and banana sensitivity coincident with ragweed pollinosis. J Allergy. 1970;45:310–9.PubMedCrossRef
50.
Antia C, Baquerizo K, Korman A, et al. Urticaria: A comprehensive review: Epidemiology, diagnosis, and work-up. J Am Acad Dermatol. 2018;79:599–614.PubMedCrossRef
51.
Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018;73:1393–414.PubMedCrossRef
52.
Hon KL, Leung AKC, Ng WGG, et al. Chronic Urticaria: An Overview of Treatment and Recent Patents. Recent Pat Inflamm Allergy Drug Discov. 2019;13:27–37.PubMedPubMedCentralCrossRef
53.
Baiardini I, Pasquali M, Braido F, et al. A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). Allergy. 2005;60:1073–8.PubMedCrossRef
54.
Staubach P, Eckhardt-Henn A, Dechene M, et al. Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br J Dermatol. 2006;154:294–8.PubMedCrossRef
55.
Fricke J, Ávila G, Keller T, et al. Prevalence of chronic urticaria in children and adults across the globe: Systematic review with meta-analysis. Allergy. 2020;75:423–32.PubMedCrossRef
56.
Brodell LA, Beck LA, Saini SS. Pathophysiology of chronic urticaria. Ann Allergy Asthma Immunol. 2008;100:291–7.PubMedCrossRef
57.
Schocket AL. Chronic urticaria: pathophysiology and etiology, or the what and why. Allergy Asthma Proc. 2006;27:90–5.PubMed
58.
Wang XY, Lim-Jurado M, Prepageran N, et al. Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine. Ther Clin Risk Manag. 2016;12:585–97.PubMedPubMedCentralCrossRef
59.
60.
Voehringer D, Reese TA, Huang X, et al. Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system. J Exp Med. 2006;203:1435–46.PubMedPubMedCentralCrossRef
61.
Wong MM, Keith PK. Presence of positive skin prick tests to inhalant allergens and markers of T2 inflammation in subjects with chronic spontaneous urticaria (CSU): a systematic literature review. Allergy Asthma Clin Immunol. 2020;16:72.PubMedPubMedCentralCrossRef
62.
Ying S, Kikuchi Y, Meng Q, et al. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol. 2002;109:694–700.PubMedCrossRef
63.
Sabroe RA, Poon E, Orchard GE, et al. Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies. J Allergy Clin Immunol. 1999;103:484–93.PubMedCrossRef
64.
Kay AB, Clark P, Maurer M, et al. Elevations in T-helper-2-initiating cytokines (interleukin-33, interleukin-25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous ('idiopathic’) urticaria. Br J Dermatol. 2015;172:1294–302.PubMedCrossRef
65.
Grattan CEH, Dawn G, Gibbs S, et al. Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity. Clin Exp Allergy. 2003;33:337–41.PubMedCrossRef
66.
67.
Coverstone AM, Seibold MA, Peters MC. Diagnosis and Management of T2-High Asthma. J Allergy Clin Immunol Pract. 2020;8:442–50.PubMedCrossRef
68.
69.
Kasperska-Zajac A, Brzoza Z. Remission of chronic urticaria in the course of house dust mite immunotherapy–mere coincidence or something more to it? Vaccine. 2009;27:7240–1.PubMedCrossRef
70.
Magerl M, Terhorst D, Metz M, et al. Benefit of mepolizumab treatment in a patient with chronic spontaneous urticaria. J Dtsch Dermatol Ges. 2018;16:477–8.PubMedCrossRef
71.
72.
Bergmann KC, Altrichter S, Maurer M. Benefit of benralizumab treatment in a patient with chronic symptomatic dermographism. J Eur Acad Dermatol Venereol. 2019;33:e413–5.PubMedCrossRef
73.
Lee JK, Simpson RS. Dupilumab as a novel therapy for difficult to treat chronic spontaneous urticaria. J Allergy Clin Immunol Pract. 2019;7:1659-1661.e1.PubMedCrossRef
74.
•• Serhan N, Basso L, Sibilano R, et al. House dust mites activate nociceptor-mast cell clusters to drive type 2 skin inflammation. Nat Immunol 2019;20:1435–1443. In vivo study showing house dust mite triggers skin mast cell degranulation via nociceptors.
75.
Fujisawa D, Kashiwakura J-I, Kita H, et al. Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria. J Allergy Clin Immunol. 2014;134:622-633.e9.PubMedCrossRef
76.
Anand MK, Nelson HS, Dreskin SC. A possible role for cyclooxygenase 2 inhibitors in the treatment of chronic urticaria. J Allergy Clin Immunol. 2003;111:1133–6.PubMedCrossRef
77.
78.
Numata T, Yamamoto S, Yamura T. The role of mite allergen in chronic urticaria. Ann Allergy. 1979;43:356–8.PubMed
79.
Ye Y-M, Hur G-Y, Park H-J, et al. Association of Specific IgE to Staphylococcal Superantigens with the Phenotype of Chronic Urticaria. J Korean Med Sci. 2008;23:845–51.PubMedPubMedCentralCrossRef
80.
81.
Lourenço FD, Azor MH, Santos JC, et al. Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus. Br J Dermatol. 2008;158:979–86.PubMedCrossRef
82.
Chen Q, Zhai Z, Xu J, et al. Basophil CD63 expression in chronic spontaneous urticaria: correlation with allergic sensitization, serum autoreactivity and basophil reactivity. J Eur Acad Dermatol Venereol. 2017;31:463–8.PubMedCrossRef
83.
Vasagar K, Vonakis BM, Gober LM, et al. Evidence of in vivo basophil activation in chronic idiopathic urticaria. Clin Exp Allergy. 2006;36:770–6.PubMedCrossRef
84.
Boumiza R, Debard A-L, Monneret G. The basophil activation test by flow cytometry: recent developments in clinical studies, standardization and emerging perspectives. Clin Mol Allergy. 2005;3:9.PubMedPubMedCentralCrossRef
85.
Yasnowsky KM, Dreskin SC, Efaw B, et al. Chronic urticaria sera increase basophil CD203c expression. J Allergy Clin Immunol. 2006;117:1430–4.PubMedCrossRef
86.
Futata E, Azor M, Dos Santos J, et al. Impaired IFN-α secretion by plasmacytoid dendritic cells induced by TLR9 activation in chronic idiopathic urticaria. Br J Dermatol. 2011;164:1271–9.PubMedCrossRef
87.
Tversky JR, Le TV, Bieneman AP, et al. Human blood dendritic cells from allergic subjects have impaired capacity to produce interferon-α via TLR9. Clin Exp Allergy. 2008;38:781–8.PubMedPubMedCentralCrossRef
88.
Caliskaner Z, Ozturk S, Turan M, et al. Skin test positivity to aeroallergens in the patients with chronic urticaria without allergic respiratory disease. J Investig Allergol Clin Immunol. 2004;14:50–4.PubMed
89.
Refaat MM, Ossman EN, Farres MN, et al. Assessment of the role of aeroallergens in patients with chronic urticaria. Revue Française d’Allergologie. 2010;50:394–7.CrossRef
90.
Ye Y-M, Yoon J, Woo S-D, et al. Clustering the Clinical Course of Chronic Urticaria Using a Longitudinal Database: Effects on Urticaria Remission. Allergy Asthma Immunol Res. 2021;13:390–403.PubMedPubMedCentralCrossRef
91.
de Vos G. Skin testing versus serum-specific IgE testing: which is better for diagnosing aeroallergen sensitization and predicting clinical allergy?. Curr Allergy Asthma Rep. 2014;14:1-8.
92.
de Vos G, Kravvariti E, Collins J, et al. Increased allergic sensitization to mugwort in chronic urticaria. Dermatology. 2012;225:141–6.PubMedCrossRef
93.
Staubach P, Vonend A, Burow G, et al. Patients with chronic urticaria exhibit increased rates of sensitization to Candida albicans, but not to common moulds. Mycoses. 2009;52:334–8.PubMedCrossRef
94.
Park H, Lee JY, Song A, et al. Natural course and prognostic factors of chronic urticaria in Korean children: A single center experience. Asian Pac J Allergy Immunol. 2019;37:19–24.PubMed
95.
Song Z, Zhai Z, Zhong H, et al. Evaluation of autologous serum skin test and skin prick test reactivity to house dust mite in patients with chronic spontaneous urticaria. PLoS One. 2013; 8: e64142.
96.
Mahesh PA, Kushalappa PA, Holla AD, et al. House dust mite sensitivity is a factor in chronic urticaria. Indian J Dermatol Venereol Leprol. 2005;71:99–101.PubMedCrossRef
97.
Daschner A, Rodero M, De Frutos C, et al. Chronic urticaria is associated with a differential helminth-arthropod-related atopy phenotype. J Dermatol. 2010;37:780–5.PubMedCrossRef
98.
Ping J-D, Zhao J-W, Sun X-X, et al. Prevalence of allergen sensitization among 1,091 patients with urticaria. Exp Ther Med. 2020;19:1908–14.PubMed
99.
Fajardo KA, Wohltmann WE. The Impact of Aeroallergens on Military Readiness: A Case Report. Mil Med. 2019;184:e945–7.PubMedCrossRef
100.
August PJ, O’Driscoll J. Urticaria successfully treated by desensitization with grass pollen extract. Br J Dermatol. 1989;120:409–10.PubMedCrossRef
101.
Kasperska-Zajac A. Exacerbation of chronic urticaria in the course of house dust mite immunotherapy. Hum Vacc. 2011;7:417–8.CrossRef
102.
103.
Eichenfield LF, Ahluwalia J, Waldman A, et al. Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines. J Allergy Clin Immunol. 2017;139:S49–57.PubMedCrossRef
Metadaten
Titel
Aeroallergens in Atopic Dermatitis and Chronic Urticaria
verfasst von
Albert C. Chong
Won Jong Chwa
Peck Y. Ong
Publikationsdatum
01.04.2022
Verlag
Springer US
Erschienen in
Current Allergy and Asthma Reports / Ausgabe 7/2022
Print ISSN: 1529-7322
Elektronische ISSN: 1534-6315
DOI
https://doi.org/10.1007/s11882-022-01033-2

Neu im Fachgebiet HNO

16.04.2024 | HNO-Chirurgie | Nachrichten

HNO-Op. auch mit über 90?

16.04.2024 | Tonsillektomie | Nachrichten

Intrakapsuläre Tonsillektomie gewinnt an Boden

15.04.2024 | Hörsturz | Nachrichten

Bilateraler Hörsturz hat eine schlechte Prognose

13.04.2024 | Klinik aktuell | Kongressbericht | Nachrichten

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“
weitere anzeigen

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen